Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

158
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
158
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

127
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
127
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

51
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
51
Schizophrenia01:17

Schizophrenia

72
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
72
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

513
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

192
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
192

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Physical and Mental Metaphors (PMM) task and its validation in schizophrenia: A tool for rapid assessment of figurative language comprehension, between pragmatics and symptoms.

Schizophrenia research. Cognition·2026
Same author

Mutations in the three synapsin genes lead to profound social deficits and cortical dysfunctions.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.

Molecular psychiatry·2026
Same author

Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.

Chembiochem : a European journal of chemical biology·2026
Same author

Increasing participation of people with thought disorder in clinical research.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions.

Neuroscience·2026

相关实验视频

Updated: Jun 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K

迷幻药和精神分裂症:一个双刃剑.

Jacopo Sapienza1,2, Francesca Martini3, Stefano Comai1,4,5,6

  • 1IRCCS San Raffaele Scientific Institute, Milan, Italy.

Molecular psychiatry
|September 18, 2024
PubMed
概括

迷幻药物显示出治疗精神分裂症的潜力,特别是负面症状和社会认知,基于生物逻辑和旧研究. 在未来的试验中,微剂量可能为特定患者群体提供安全的策略.

更多相关视频

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.5K

相关实验视频

Last Updated: Jun 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.5K

科学领域:

  • 精神病学是一个精神病学.
  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 迷幻药在各种精神疾病中显示出治疗的前景.
  • 由于心理模拟的担忧,对精神分裂症的迷幻药物进行的现代研究有限.
  • 20世纪50年代至60年代的历史研究表明,对精神分裂症患者的负面症状和社会认知有好处.

研究的目的:

  • 审查精神分裂症的历史迷幻研究.
  • 将这些发现与最近的迷幻药的分子机制一起解释.
  • 探索幻觉药物在精神分裂症治疗中的潜在治疗作用.

主要方法:

  • 这是一篇视角论文,回顾了关于迷幻药和精神分裂症的历史性,半事研究.
  • 根据目前对迷幻神经生物学的理解来解释研究结果.
  • 确定潜在的治疗策略和患者亚群.

主要成果:

  • 历史研究表明,负面症状和社会认知可能有所改善.
  • 迷幻的作用机制,包括神经可塑性和系统调节,与精神分裂症的病理生理学保持一致.
  • 一个患有负面症状的慢性患者的亚群可能会从微剂量中受益.

结论:

  • 尽管有历史上的担忧,但迷幻药对精神分裂症治疗具有生物学理由.
  • 在非常低的剂量中微量服用迷幻药物对特定的精神分裂症患者来说是一个潜在的策略.
  • 进一步的临床试验是有必要的,以调查精神错乱药物在精神分裂症中的安全性和有效性.